Search

Your search keyword '"Planchamp, François"' showing total 23 results
Start Over Author "Planchamp, François" Publisher bmj
23 results on '"Planchamp, François"'

1. European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management

Author

Fotopoulou, Christina, primary, Eriksson, Ane Gerda, additional, Planchamp, François, additional, Morice, Philippe, additional, Taylor, Alexandra, additional, Sturdza, Alina, additional, Florin Coza, Ovidiu, additional, Halaska, Michael J, additional, Martinelli, Fabio, additional, Armbrust, Robert, additional, and Chargari, Cyrus, additional

Published
2024
Full Text
View/download PDF

2. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023

Author

Oonk, Maaike H M, primary, Planchamp, François, additional, Baldwin, Peter, additional, Mahner, Sven, additional, Mirza, Mansoor Raza, additional, Fischerová, Daniela, additional, Creutzberg, Carien L, additional, Guillot, Eugénie, additional, Garganese, Giorgia, additional, Lax, Sigurd, additional, Redondo, Andres, additional, Sturdza, Alina, additional, Taylor, Alexandra, additional, Ulrikh, Elena, additional, Vandecaveye, Vincent, additional, van der Zee, Ate, additional, Wölber, Linn, additional, Zach, Diana, additional, Zannoni, Gian Franco, additional, and Zapardiel, Ignacio, additional

Published
2023
Full Text
View/download PDF

3. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

Author

Chargari, Cyrus, primary, Tanderup, Kari, additional, Planchamp, François, additional, Chiva, Luis, additional, Humphrey, Pauline, additional, Sturdza, Alina, additional, Tan, Li T, additional, van der Steen-Banasik, Elzbieta, additional, Zapardiel, Ignacio, additional, Nout, Remi A, additional, and Fotopoulou, Christina, additional

Published
2023
Full Text
View/download PDF

4. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

Author

Cibula, David, primary, Raspollini, Maria Rosaria, additional, Planchamp, François, additional, Centeno, Carlos, additional, Chargari, Cyrus, additional, Felix, Ana, additional, Fischerová, Daniela, additional, Jahnn-Kuch, Daniela, additional, Joly, Florence, additional, Kohler, Christhardt, additional, Lax, Sigurd, additional, Lorusso, Domenica, additional, Mahantshetty, Umesh, additional, Mathevet, Patrice, additional, Naik, Raj, additional, Nout, Remi A, additional, Oaknin, Ana, additional, Peccatori, Fedro, additional, Persson, Jan, additional, Querleu, Denis, additional, Bernabé, Sandra Rubio, additional, Schmid, Maximilian P, additional, Stepanyan, Artem, additional, Svintsitskyi, Valentyn, additional, Tamussino, Karl, additional, Zapardiel, Ignacio, additional, and Lindegaard, Jacob, additional

Published
2023
Full Text
View/download PDF

5. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia

Author

Kesic, Vesna, primary, Carcopino, Xavier, additional, Preti, Mario, additional, Vieira-Baptista, Pedro, additional, Bevilacqua, Federica, additional, Bornstein, Jacob, additional, Chargari, Cyrus, additional, Cruickshank, Maggie, additional, Erzeneoglu, Emre, additional, Gallio, Niccolò, additional, Gultekin, Murat, additional, Heller, Debra, additional, Joura, Elmar, additional, Kyrgiou, Maria, additional, Madić, Tatjana, additional, Planchamp, François, additional, Regauer, Sigrid, additional, Reich, Olaf, additional, Esat Temiz, Bilal, additional, Woelber, Linn, additional, Zodzika, Jana, additional, and Stockdale, Colleen, additional

Published
2023
Full Text
View/download PDF

7. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

Author

Rodolakis, Alexandros, primary, Scambia, Giovanni, additional, Planchamp, François, additional, Acien, Maribel, additional, Di Spiezio Sardo, Attilio, additional, Farrugia, Martin, additional, Grynberg, Michael, additional, Pakiz, Maja, additional, Pavlakis, Kitty, additional, Vermeulen, Nathalie, additional, Zannoni, Gianfranco, additional, Zapardiel, Ignacio, additional, and Macklon, Kirsten Louise Tryde, additional

Published
2023
Full Text
View/download PDF

8. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions

Author

Preti, Mario, primary, Joura, Elmar, additional, Vieira-Baptista, Pedro, additional, Van Beurden, Marc, additional, Bevilacqua, Federica, additional, Bleeker, Maaike C G, additional, Bornstein, Jacob, additional, Carcopino, Xavier, additional, Chargari, Cyrus, additional, Cruickshank, Margaret E, additional, Erzeneoglu, Bilal Emre, additional, Gallio, Niccolò, additional, Heller, Debra, additional, Kesic, Vesna, additional, Reich, Olaf, additional, Stockdale, Colleen K, additional, Esat Temiz, Bilal, additional, Woelber, Linn, additional, Planchamp, François, additional, Zodzika, Jana, additional, Querleu, Denis, additional, and Gultekin, Murat, additional

Published
2022
Full Text
View/download PDF

9. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma

Author

Concin, Nicole, primary, Planchamp, François, additional, Abu-Rustum, Nadeem R, additional, Ataseven, Beyhan, additional, Cibula, David, additional, Fagotti, Anna, additional, Fotopoulou, Christina, additional, Knapp, Pawel, additional, Marth, Christian, additional, Morice, Philippe, additional, Querleu, Denis, additional, Sehouli, Jalid, additional, Stepanyan, Artem, additional, Taskiran, Cagatay, additional, Vergote, Ignace, additional, Wimberger, Pauline, additional, Zapardiel, Ignacio, additional, and Persson, Jan, additional

Published
2021
Full Text
View/download PDF

10. Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al

Author

Timmerman, Dirk, primary, Cibula, David, additional, Planchamp, François, additional, Bourne, Tom, additional, Landolfo, Chiara, additional, Testa, Antonia Carla, additional, du Bois, Andreas, additional, Chiva, Luis, additional, Concin, Nicole, additional, fisherova, Daniela, additional, Froyman, Wouter, additional, Lemley, Birthe, additional, Loft, Annika, additional, Mereu, Liliana, additional, Morice, Philippe, additional, Querleu, Denis, additional, Vergote, Ignace, additional, Vandecaveye, Vincent, additional, Scambia, Giovanni, additional, and Fotopoulou, Christina, additional

Published
2021
Full Text
View/download PDF

11. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

Author

Fotopoulou, Christina, primary, Planchamp, François, additional, Aytulu, Tugce, additional, Chiva, Luis, additional, Cina, Alessandro, additional, Ergönül, Önder, additional, Fagotti, Anna, additional, Haidopoulos, Dimitrios, additional, Hasenburg, Annette, additional, Hughes, Cathy, additional, Knapp, Pawel, additional, Morice, Philippe, additional, Schneider, Stephanie, additional, Sehouli, Jalid, additional, Stamatakis, Emmanouil, additional, Suria, Stephanie, additional, Taskiran, Cagatay, additional, Trappe, Ralf Ulrich, additional, and Campbell, Jeremy, additional

Published
2021
Full Text
View/download PDF

12. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

Author

Timmerman, Dirk, primary, Planchamp, François, additional, Bourne, Tom, additional, Landolfo, Chiara, additional, du Bois, Andreas, additional, Chiva, Luis, additional, Cibula, David, additional, Concin, Nicole, additional, Fischerova, Daniela, additional, Froyman, Wouter, additional, Gallardo Madueño, Guillermo, additional, Lemley, Birthe, additional, Loft, Annika, additional, Mereu, Liliana, additional, Morice, Philippe, additional, Querleu, Denis, additional, Testa, Antonia Carla, additional, Vergote, Ignace, additional, Vandecaveye, Vincent, additional, Scambia, Giovanni, additional, and Fotopoulou, Christina, additional

Published
2021
Full Text
View/download PDF

13. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Author

Concin, Nicole, primary, Matias-Guiu, Xavier, additional, Vergote, Ignace, additional, Cibula, David, additional, Mirza, Mansoor Raza, additional, Marnitz, Simone, additional, Ledermann, Jonathan, additional, Bosse, Tjalling, additional, Chargari, Cyrus, additional, Fagotti, Anna, additional, Fotopoulou, Christina, additional, Gonzalez Martin, Antonio, additional, Lax, Sigurd, additional, Lorusso, Domenica, additional, Marth, Christian, additional, Morice, Philippe, additional, Nout, Remi A, additional, O'Donnell, Dearbhaile, additional, Querleu, Denis, additional, Raspollini, Maria Rosaria, additional, Sehouli, Jalid, additional, Sturdza, Alina, additional, Taylor, Alexandra, additional, Westermann, Anneke, additional, Wimberger, Pauline, additional, Colombo, Nicoletta, additional, Planchamp, François, additional, and Creutzberg, Carien L, additional

Published
2020
Full Text
View/download PDF

15. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

Author

Cibula, David, primary, Planchamp, François, additional, Fischerova, Daniela, additional, Fotopoulou, Christina, additional, Kohler, Christhardt, additional, Landoni, Fabio, additional, Mathevet, Patrice, additional, Naik, Raj, additional, Ponce, Jordi, additional, Raspagliesi, Francesco, additional, Rodolakis, Alexandros, additional, Tamussino, Karl, additional, Taskiran, Cagatay, additional, Vergote, Ignace, additional, Wimberger, Pauline, additional, Zahl Eriksson, Ane Gerda, additional, and Querleu, Denis, additional

Published
2020
Full Text
View/download PDF

16. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer

Author

Cibula, David, primary, Pötter, Richard, additional, Planchamp, François, additional, Avall-Lundqvist, Elisabeth, additional, Fischerova, Daniela, additional, Haie Meder, Christine, additional, Köhler, Christhardt, additional, Landoni, Fabio, additional, Lax, Sigurd, additional, Lindegaard, Jacob Christian, additional, Mahantshetty, Umesh, additional, Mathevet, Patrice, additional, McCluggage, W. Glenn, additional, McCormack, Mary, additional, Naik, Raj, additional, Nout, Remi, additional, Pignata, Sandro, additional, Ponce, Jordi, additional, Querleu, Denis, additional, Raspagliesi, Francesco, additional, Rodolakis, Alexandros, additional, Tamussino, Karl, additional, Wimberger, Pauline, additional, and Raspollini, Maria Rosaria, additional

Published
2018
Full Text
View/download PDF

17. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

Author

Querleu, Denis, primary, Planchamp, François, additional, Chiva, Luis, additional, Fotopoulou, Christina, additional, Barton, Desmond, additional, Cibula, David, additional, Aletti, Giovanni, additional, Carinelli, Silvestro, additional, Creutzberg, Carien, additional, Davidson, Ben, additional, Harter, Philip, additional, Lundvall, Lene, additional, Marth, Christian, additional, Morice, Philippe, additional, Rafii, Arash, additional, Ray-Coquard, Isabelle, additional, Rockall, Andrea, additional, Sessa, Christiana, additional, van der Zee, Ate, additional, Vergote, Ignace, additional, and duBois, Andreas, additional

Published
2017
Full Text
View/download PDF

18. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

Author

Oonk, Maaike H.M., primary, Planchamp, François, additional, Baldwin, Peter, additional, Bidzinski, Mariusz, additional, Brännström, Mats, additional, Landoni, Fabio, additional, Mahner, Sven, additional, Mahantshetty, Umesh, additional, Mirza, Mansoor, additional, Petersen, Cordula, additional, Querleu, Denis, additional, Regauer, Sigrid, additional, Rob, Lukas, additional, Rouzier, Roman, additional, Ulrikh, Elena, additional, van der Velden, Jacobus, additional, Vergote, Ignace, additional, Woelber, Linn, additional, and van der Zee, Ate G.J., additional

Published
2017
Full Text
View/download PDF

19. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery

Author

Querleu, Denis, primary, Planchamp, François, additional, Chiva, Luis, additional, Fotopoulou, Christina, additional, Barton, Desmond, additional, Cibula, David, additional, Aletti, Giovanni, additional, Carinelli, Silvestro, additional, Creutzberg, Carien, additional, Davidson, Ben, additional, Harter, Philip, additional, Lundvall, Lene, additional, Marth, Christian, additional, Morice, Philippe, additional, Rafii, Arash, additional, Ray-Coquard, Isabelle, additional, Rockall, Andrea, additional, Sessa, Cristiana, additional, van der Zee, Ate, additional, Vergote, Ignace, additional, and du Bois, Andreas, additional

Published
2016
Full Text
View/download PDF

20. Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France

Author

Querleu, Denis, primary, Planchamp, François, additional, Narducci, Fabrice, additional, Morice, Philippe, additional, Joly, Florence, additional, Genestie, Catherine, additional, Haie-Meder, Christine, additional, Thomas, Laurence, additional, Quénel-Tueux, Nathalie, additional, Daraï, Emile, additional, Dorangeon, Pierre-Hervé, additional, Marret, Henri, additional, Taïeb, Sophie, additional, and Mazeau-Woynar, Valérie, additional

Published
2011
Full Text
View/download PDF

21. ESTRO/ESGO/SIOPe Guidelines for the management of patients with vaginal cancer.

Author

Nout RA, Calaminus G, Planchamp F, Chargari C, Lax S, Martelli H, McCluggage WG, Morice P, Pakiz M, Schmid MP, Stunt J, Timmermann B, Vokuhl C, Orbach D, and Fotopoulou C

Subjects
Adult, Female, Humans, Child, Medical Oncology, Vaginal Neoplasms therapy, Radiation Oncology, Gynecology, Genital Neoplasms, Female, Carcinoma in Situ
Abstract

Primary vaginal malignancies are rare, comprising only 2% of all female genital tract malignancies in adults and 4.5% in children. As part of its mission to improve the quality of care for women with gynecological cancers across Europe, the European Society of Gynaecological Oncology (ESGO) jointly with the European Society for Radiotherapy & Oncology (ESTRO) and the European Society of Pediatric Oncology (SIOPe) developed evidence-based guidelines in order to improve the management of patients with vaginal cancer within a multidisciplinary setting.ESTRO/ESGO/SIOPe nominated practicing clinicians who are involved in the management of vaginal cancer patients and have demonstrated leadership through their expertise in clinical care and research, their national and international engagement and profile as well as dedication to the topics addressed to serve on the expert panel (13 experts across Europe comprising the international development group). To ensure that the statements were evidence based, the current literature was reviewed and critically appraised.In the case of absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the international development group. Prior to publication, the guidelines were reviewed by 112 independent international practitionners in cancer care delivery and patient representatives and their comments and input were incorporated and addressed accordingly.These guidelines cover comprehensively the diagnostic pathways as well as the surgical, radiotherapeutical and systemic management and follow-up of adult patients (including those with rare histological subtypes) and pediatric patients (vaginal rhabdomyosarcoma and germ cell tumours) with vaginal tumours., Competing Interests: Competing interests: CC has reported advisory boards for GSK and MSD; SL has reported advisory boards for GSK, MSD, Novartis and AstraZeneca;MPS has reported grants and personal fees for workshops from Elekta AB; CF has reported advisory board for Roche, Tesaro, GSK, MDS/AZ, Clovis., (© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2023
Full Text
View/download PDF

22. An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.

Author

Gaillard T, Schwameis R, Laas-Faron E, Eisenberg-Nissim T, Matias-Guiu X, Creutzberg CL, Ledermann J, Planchamp F, and Concin N

Subjects
Female, Humans, Standard of Care, Mobile Applications, Radiation Oncology, Endometrial Neoplasms diagnosis, Endometrial Neoplasms therapy, Endometrial Neoplasms pathology
Abstract

The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly published comprehensive evidence-based guidelines on all relevant issues of diagnosis and treatment in endometrial carcinoma in a multidisciplinary setting. In order to improve their implementation, a free downloadable easy-to-use mobile app was developed.Two interactive decision tools were created for (1) helping users to identify the recommended surgical steps, especially in terms of nodal staging approach based on the pre-operatively assumed risk group (tool #1), and (2) to facilitate prognostic risk group allocation and adjuvant treatment decision-making after primary surgery integrating both clinicopathological and molecular markers (if known) (tool #2). Algorithms and readable guidelines were also incorporated into the mobile app on all relevant issues of diagnosis and treatment. The scientific content presented in the app will be updated and modified in the future based on new evidence and user feedback.This article presents the decision tools and two practical examples of using these calculators to illustrate that the ESGO mobile app (available without the necessity of an internet connection) can provide fast and accurate responses to complex clinical questions that require the evaluation of numerous parameters., Competing Interests: Competing interests: The research activity of XMG is supported by Asociación Española Contra el Cáncer (AECC). TG, RS, ELF, TEN, CLC, JL, FP, and NC have reported no conflicts of interest., (© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2023
Full Text
View/download PDF

23. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

Author

Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O'Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, and Creutzberg CL

Subjects
Endometrial Neoplasms pathology, Europe, Female, Humans, Preoperative Care, Risk Factors, Endometrial Neoplasms diagnosis, Endometrial Neoplasms therapy, Genital Neoplasms, Female diagnosis, Genital Neoplasms, Female therapy, Medical Oncology standards
Abstract

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide., Competing Interests: Competing interests: NCon: advisory boards for Seattle Genetics, AstraZeneca and Mersana, education fees from Medscape Oncology, and grants for travelling from Roche, Genmab and Amgen. IV: advisory boards for Amgen, AstraZeneca, Clovis Oncology, Carrick Therapeutics, Debiopharm International, F Hoffmann-La Roche, Genmab, GSK, Immunogen, Millenium Pharmaceuticals, MSD Belgium, Octimet Oncology, Oncoinvent, Pharmamar-Doctaforum Servicios, Roche, Sotio, Tesaro, Deciphera Pharmaceuticals and Verastem Oncology (fees for consulting to his university), contracted research (KU Leuven) for Oncoinvent AS and Genmab, corporate sponsored research for Amgen and Roche, and grants for travelling from Amgen, MSD/Merck, Roche, AstraZeneca and Tesaro. DC: advisory boards for AstraZeneca, Roche, Sotio and Novocure. MRM: personal financial interests for AstraZeneca, Biocard, Clovis Oncology, Geneos, Genmab, Karyopharm Therapeutics, Merck, Mersana, MSD, Oncology Venture, Pfizer, Roche, SeatleGenetics, SeraPrognostics, Sotio, Tesaro-GSK, ZaiLab; leadership role for Karyopharm Therapeutics, Sera Prognostics; institutional financial interests (study grants) for AstraZeneca, Boehringer Ingelheim, Clovis Oncology, Pfizer, Tesaro-GSK, Ultimovacs. JL: advisory boards for AstraZeneca, Pfizer, GSK, Eisai, MSD/Merck, Artios Pharma, Regeneron, Amgen and Clovis Oncology, and grants for travelling from Clovis Oncology. CC: advisory boards for MSD, Takeda and GSK, conducting research for TherAguiX and Roche, and grants for travelling from Takeda. AF: advisory boards for GSK and Johnson & Johnson SpA, and grants for travelling from Pharmmar and MSD Italia. CF: advisory boards for AstraZeneca, Clovis, Ethicon, Roche, MSD, GSK and Tesaro, and grants for travelling from Sequana. AGM: speakers’ bureau activities for AstraZeneca, Pharmamar, Roche and GSK, advisory boards for Amgen, AstraZeneca, Clovis Oncology, Genmab, GSK, Immunogen, Merck Sharp & Dohme, Novartis, Oncoinvent, Pfizer/Merck, Pharmamar, Roche and Sotio, and grants for travelling from AstraZeneca, Pharmamar Roche and Tesaro. DL: advisory boards for Roche, Amgen, MSD, GSK, Clovis, AstraZeneca, Immunogen, Genmab, Pharmamar and Merck, and grants for travelling from Pharmamar, GSK, Roche and AstraZeneca. CM: consulting/advisory boards for Roche, Novartis, Amgen, MSD, AstraZeneca, Pfizer, Pharmamar, Cerulean, Vertex and Tesaro, funded research from EU, FWF, AstraZeneca and Roche, and honoraria/expenses from Roche, Novartis, Amgen, MSD, Pharmamar, AstraZeneca and Tesaro. JS: advisory boards for Roche, Eisei, MSD, AstraZeneca, Clovis, GSK and Tesaro. AT: advisory boards for Genmab; PW: advisory boards for Amgen, AstraZeneca, MSD, Novartis, Pfizer, Pharmamar, Lilly, Roche Pharma GmbH, TEVA, Eisai, Clovis and Tesaro, and grants for travelling from Roche Pharma GmbH, AstraZeneca, MSD, Amgen and Pfizer. NC: consulting and advisory services, speaking or writing engagements, public presentations for Roche, AstraZeneca, MSD, Pharmamar, Tesaro, GSK, Clovis, Advaxis, Pfizer, Takeda, Immunogen, Biocad, Amgen, Novartis and Ellipses, institutional financial interests for Roche, Pharmamar and AstraZeneca, and non-financial interests for ESMO clinical Guidelines (subject editor for gynecological cancer). XMG, SM, TB, SL, PM, RN, DOD, DQ, MRR, AS, AW, FP, and CLC: no conflicts of interest., (© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results